Dr. Vera Lucía Gomes Francisco

Emerging Investigator
Research Group on Cardiometabolic Risk and Diabetes


Dr. Vera Francisco has a degree in Biochemistry and a PhD in Health Sciences and Technologies from the University of Coimbra, Portugal. As a post-doctoral researcher, she carried out 3 EASD Fellowships at the Alberto Sols Biomedical Research Institute (Madrid) where she specialized in metabolic diseases. After obtaining a contract, Sara Borrell (ISCIII), joined the Santiago de Compostela Health Research Institute where she focused her research on the role of adipokines, molecules released by adipose tissue, in the development of metabolic and inflammatory diseases, in the field of translational research.

Since 2022, she obtained a Miguel Servet contract (ISCIII). She is an emerging researcher at INCLIVA. Her work focuses on establishing new biomarkers and therapeutic targets in metabolic and cardiovascular diseases, highlighting the role of new adipokines and inflammatory axes.

She has participated in European projects, national competitive projects and collaborative projects with the pharmaceutical industry. She is the author of 36 papers (24 in the first quartile, 5 as a corresponding author) and 2 book chapters. She is also a reviewer of articles in international journals and “Guest editor” of the journal Biology.

Dr. Vera Lucía Gomes Francisco


Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?. Domingo E, Marques P, Francisco V, Piqueras L, Sanz M. Pharmacological Research. 2024 Jan 11:S0214-9168(23)00120-1. doi: 10.1016/j.arteri.2023.12.005. PMID: 38218355